Retinal Vein Occlusion Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Branch Retinal Artery Occlusion, Central Retinal Vein Occlusion); Condition (Non-Ischemic, Ischemic); Diagnosis (Optical Coherence Tomography, Fundoscopic Examination, Fluorescein Angiography); Treatment (Antivascular Endothelial Growth Factor, Corticosteroid Drugs, Laser Retinal Photocoagulation); End User (Hospitals, Clinics, Research and Academics Centers) and Geography

Report Code: TIPRE00017831 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

In retinal vein occlusion the blockage of retinal vein occur due to blood clot. It is second most common cause of visual impairment worldwide. Blood clot causes blockage in the vein, which starts draining blood from retina, resulting in swelling and bleeding, affecting the vision of the person. The primary factors causing retinal vein occlusion are atherosclerosis, hypertension, and eye conditions such as glaucoma and vitreous hemorrhage.

MARKET DYNAMICS

The retinal vein occlusion market is driving due to the rise in eye diseases globally, and increase in geriatric population coupled with surge in awareness about eye disease. However, side effects associated with are expected to hamper the growth of the global Retinal Vein Occlusion market.

MARKET SCOPE

The "Retinal Vein Occlusion Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of retinal vein occlusion market with detailed market segmentation by type, condition, diagnosis, treatment and end user. The Retinal Vein Occlusion market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Retinal Vein Occlusion market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The retinal vein occlusion market is segmented on the basis of type, condition, diagnosis, treatment and end user. Based on type, the market is segmented as Branch Retinal Artery Occlusion and Central Retinal Vein Occlusion. On the basis of Condition, the market is categorized as Non-Ischemic and Ischemic. On the basis of diagnosis the market is segmented into Optical Coherence Tomography, Fundoscopic Examination and Fluorescein Angiography. On the basis of treatment the market is segmented into Antivascular Endothelial Growth Factor, Corticosteroid Drugs and Laser Retinal Photocoagulation. On the basis of end user the market is segmented into Hospitals and Clinics and Research and Academics Centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Retinal Vein Occlusion market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Retinal Vein Occlusion market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Retinal Vein Occlusion market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Retinal Vein Occlusion market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Retinal Vein Occlusion market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Retinal Vein Occlusion market are anticipated to have lucrative growth opportunities in the future with the rising demand for Retinal Vein Occlusion in the global market. Below mentioned is the list of few companies engaged in the Retinal Vein Occlusion market.

The report also includes the profiles of key players in Retinal Vein Occlusion market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Allergan PLC
  •  Bayer
  •  Bristol-Myers Squibb
  •  Ellex Medical Lasers Ltd
  •  GlaxoSmithKline PLC
  •  IRIDEX Corporation
  •  Lumenis
  •  Novartis AG
  •  NIDEK CO., LTD
  •  Regeneron Pharmaceuticals

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Retinal Vein Occlusion Market - By Type
1.3.2 Retinal Vein Occlusion Market - By Condition
1.3.3 Retinal Vein Occlusion Market - By Diagnosis
1.3.4 Retinal Vein Occlusion Market - By Treatment
1.3.5 Retinal Vein Occlusion Market - By End User
1.3.6 Retinal Vein Occlusion Market - By Region
1.3.6.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. RETINAL VEIN OCCLUSION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. RETINAL VEIN OCCLUSION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. RETINAL VEIN OCCLUSION MARKET - GLOBAL MARKET ANALYSIS
6.1. RETINAL VEIN OCCLUSION - GLOBAL MARKET OVERVIEW
6.2. RETINAL VEIN OCCLUSION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. RETINAL VEIN OCCLUSION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BRANCH RETINAL ARTERY OCCLUSION
7.3.1. Overview
7.3.2. Branch Retinal Artery Occlusion Market Forecast and Analysis
7.4. CENTRAL RETINAL VEIN OCCLUSION
7.4.1. Overview
7.4.2. Central Retinal Vein Occlusion Market Forecast and Analysis
8. RETINAL VEIN OCCLUSION MARKET - REVENUE AND FORECASTS TO 2028 - CONDITION
8.1. OVERVIEW
8.2. CONDITION MARKET FORECASTS AND ANALYSIS
8.3. NON-ISCHEMIC
8.3.1. Overview
8.3.2. Non-Ischemic Market Forecast and Analysis
8.4. ISCHEMIC
8.4.1. Overview
8.4.2. Ischemic Market Forecast and Analysis
9. RETINAL VEIN OCCLUSION MARKET - REVENUE AND FORECASTS TO 2028 - DIAGNOSIS
9.1. OVERVIEW
9.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
9.3. OPTICAL COHERENCE TOMOGRAPHY
9.3.1. Overview
9.3.2. Optical Coherence Tomography Market Forecast and Analysis
9.4. FUNDOSCOPIC EXAMINATION
9.4.1. Overview
9.4.2. Fundoscopic Examination Market Forecast and Analysis
9.5. FLUORESCEIN ANGIOGRAPHY
9.5.1. Overview
9.5.2. Fluorescein Angiography Market Forecast and Analysis
10. RETINAL VEIN OCCLUSION MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
10.1. OVERVIEW
10.2. TREATMENT MARKET FORECASTS AND ANALYSIS
10.3. ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR
10.3.1. Overview
10.3.2. Antivascular Endothelial Growth Factor Market Forecast and Analysis
10.4. CORTICOSTEROID DRUGS
10.4.1. Overview
10.4.2. Corticosteroid Drugs Market Forecast and Analysis
10.5. LASER RETINAL PHOTOCOAGULATION
10.5.1. Overview
10.5.2. Laser Retinal Photocoagulation Market Forecast and Analysis
11. RETINAL VEIN OCCLUSION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS
11.3.1. Overview
11.3.2. Hospitals Market Forecast and Analysis
11.4. CLINICS
11.4.1. Overview
11.4.2. Clinics Market Forecast and Analysis
11.5. RESEARCH AND ACADEMICS CENTERS
11.5.1. Overview
11.5.2. Research and Academics Centers Market Forecast and Analysis

12. RETINAL VEIN OCCLUSION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Retinal Vein Occlusion Market Overview
12.1.2 North America Retinal Vein Occlusion Market Forecasts and Analysis
12.1.3 North America Retinal Vein Occlusion Market Forecasts and Analysis - By Type
12.1.4 North America Retinal Vein Occlusion Market Forecasts and Analysis - By Condition
12.1.5 North America Retinal Vein Occlusion Market Forecasts and Analysis - By Diagnosis
12.1.6 North America Retinal Vein Occlusion Market Forecasts and Analysis - By Treatment
12.1.7 North America Retinal Vein Occlusion Market Forecasts and Analysis - By End User
12.1.8 North America Retinal Vein Occlusion Market Forecasts and Analysis - By Countries
12.1.8.1 United States Retinal Vein Occlusion Market
12.1.8.1.1 United States Retinal Vein Occlusion Market by Type
12.1.8.1.2 United States Retinal Vein Occlusion Market by Condition
12.1.8.1.3 United States Retinal Vein Occlusion Market by Diagnosis
12.1.8.1.4 United States Retinal Vein Occlusion Market by Treatment
12.1.8.1.5 United States Retinal Vein Occlusion Market by End User
12.1.8.2 Canada Retinal Vein Occlusion Market
12.1.8.2.1 Canada Retinal Vein Occlusion Market by Type
12.1.8.2.2 Canada Retinal Vein Occlusion Market by Condition
12.1.8.2.3 Canada Retinal Vein Occlusion Market by Diagnosis
12.1.8.2.4 Canada Retinal Vein Occlusion Market by Treatment
12.1.8.2.5 Canada Retinal Vein Occlusion Market by End User
12.1.8.3 Mexico Retinal Vein Occlusion Market
12.1.8.3.1 Mexico Retinal Vein Occlusion Market by Type
12.1.8.3.2 Mexico Retinal Vein Occlusion Market by Condition
12.1.8.3.3 Mexico Retinal Vein Occlusion Market by Diagnosis
12.1.8.3.4 Mexico Retinal Vein Occlusion Market by Treatment
12.1.8.3.5 Mexico Retinal Vein Occlusion Market by End User
12.2. EUROPE
12.2.1 Europe Retinal Vein Occlusion Market Overview
12.2.2 Europe Retinal Vein Occlusion Market Forecasts and Analysis
12.2.3 Europe Retinal Vein Occlusion Market Forecasts and Analysis - By Type
12.2.4 Europe Retinal Vein Occlusion Market Forecasts and Analysis - By Condition
12.2.5 Europe Retinal Vein Occlusion Market Forecasts and Analysis - By Diagnosis
12.2.6 Europe Retinal Vein Occlusion Market Forecasts and Analysis - By Treatment
12.2.7 Europe Retinal Vein Occlusion Market Forecasts and Analysis - By End User
12.2.8 Europe Retinal Vein Occlusion Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Retinal Vein Occlusion Market
12.2.8.1.1 Germany Retinal Vein Occlusion Market by Type
12.2.8.1.2 Germany Retinal Vein Occlusion Market by Condition
12.2.8.1.3 Germany Retinal Vein Occlusion Market by Diagnosis
12.2.8.1.4 Germany Retinal Vein Occlusion Market by Treatment
12.2.8.1.5 Germany Retinal Vein Occlusion Market by End User
12.2.8.2 France Retinal Vein Occlusion Market
12.2.8.2.1 France Retinal Vein Occlusion Market by Type
12.2.8.2.2 France Retinal Vein Occlusion Market by Condition
12.2.8.2.3 France Retinal Vein Occlusion Market by Diagnosis
12.2.8.2.4 France Retinal Vein Occlusion Market by Treatment
12.2.8.2.5 France Retinal Vein Occlusion Market by End User
12.2.8.3 Italy Retinal Vein Occlusion Market
12.2.8.3.1 Italy Retinal Vein Occlusion Market by Type
12.2.8.3.2 Italy Retinal Vein Occlusion Market by Condition
12.2.8.3.3 Italy Retinal Vein Occlusion Market by Diagnosis
12.2.8.3.4 Italy Retinal Vein Occlusion Market by Treatment
12.2.8.3.5 Italy Retinal Vein Occlusion Market by End User
12.2.8.4 Spain Retinal Vein Occlusion Market
12.2.8.4.1 Spain Retinal Vein Occlusion Market by Type
12.2.8.4.2 Spain Retinal Vein Occlusion Market by Condition
12.2.8.4.3 Spain Retinal Vein Occlusion Market by Diagnosis
12.2.8.4.4 Spain Retinal Vein Occlusion Market by Treatment
12.2.8.4.5 Spain Retinal Vein Occlusion Market by End User
12.2.8.5 United Kingdom Retinal Vein Occlusion Market
12.2.8.5.1 United Kingdom Retinal Vein Occlusion Market by Type
12.2.8.5.2 United Kingdom Retinal Vein Occlusion Market by Condition
12.2.8.5.3 United Kingdom Retinal Vein Occlusion Market by Diagnosis
12.2.8.5.4 United Kingdom Retinal Vein Occlusion Market by Treatment
12.2.8.5.5 United Kingdom Retinal Vein Occlusion Market by End User
12.2.8.6 Rest of Europe Retinal Vein Occlusion Market
12.2.8.6.1 Rest of Europe Retinal Vein Occlusion Market by Type
12.2.8.6.2 Rest of Europe Retinal Vein Occlusion Market by Condition
12.2.8.6.3 Rest of Europe Retinal Vein Occlusion Market by Diagnosis
12.2.8.6.4 Rest of Europe Retinal Vein Occlusion Market by Treatment
12.2.8.6.5 Rest of Europe Retinal Vein Occlusion Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Retinal Vein Occlusion Market Overview
12.3.2 Asia-Pacific Retinal Vein Occlusion Market Forecasts and Analysis
12.3.3 Asia-Pacific Retinal Vein Occlusion Market Forecasts and Analysis - By Type
12.3.4 Asia-Pacific Retinal Vein Occlusion Market Forecasts and Analysis - By Condition
12.3.5 Asia-Pacific Retinal Vein Occlusion Market Forecasts and Analysis - By Diagnosis
12.3.6 Asia-Pacific Retinal Vein Occlusion Market Forecasts and Analysis - By Treatment
12.3.7 Asia-Pacific Retinal Vein Occlusion Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Retinal Vein Occlusion Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Retinal Vein Occlusion Market
12.3.8.1.1 Australia Retinal Vein Occlusion Market by Type
12.3.8.1.2 Australia Retinal Vein Occlusion Market by Condition
12.3.8.1.3 Australia Retinal Vein Occlusion Market by Diagnosis
12.3.8.1.4 Australia Retinal Vein Occlusion Market by Treatment
12.3.8.1.5 Australia Retinal Vein Occlusion Market by End User
12.3.8.2 China Retinal Vein Occlusion Market
12.3.8.2.1 China Retinal Vein Occlusion Market by Type
12.3.8.2.2 China Retinal Vein Occlusion Market by Condition
12.3.8.2.3 China Retinal Vein Occlusion Market by Diagnosis
12.3.8.2.4 China Retinal Vein Occlusion Market by Treatment
12.3.8.2.5 China Retinal Vein Occlusion Market by End User
12.3.8.3 India Retinal Vein Occlusion Market
12.3.8.3.1 India Retinal Vein Occlusion Market by Type
12.3.8.3.2 India Retinal Vein Occlusion Market by Condition
12.3.8.3.3 India Retinal Vein Occlusion Market by Diagnosis
12.3.8.3.4 India Retinal Vein Occlusion Market by Treatment
12.3.8.3.5 India Retinal Vein Occlusion Market by End User
12.3.8.4 Japan Retinal Vein Occlusion Market
12.3.8.4.1 Japan Retinal Vein Occlusion Market by Type
12.3.8.4.2 Japan Retinal Vein Occlusion Market by Condition
12.3.8.4.3 Japan Retinal Vein Occlusion Market by Diagnosis
12.3.8.4.4 Japan Retinal Vein Occlusion Market by Treatment
12.3.8.4.5 Japan Retinal Vein Occlusion Market by End User
12.3.8.5 South Korea Retinal Vein Occlusion Market
12.3.8.5.1 South Korea Retinal Vein Occlusion Market by Type
12.3.8.5.2 South Korea Retinal Vein Occlusion Market by Condition
12.3.8.5.3 South Korea Retinal Vein Occlusion Market by Diagnosis
12.3.8.5.4 South Korea Retinal Vein Occlusion Market by Treatment
12.3.8.5.5 South Korea Retinal Vein Occlusion Market by End User
12.3.8.6 Rest of Asia-Pacific Retinal Vein Occlusion Market
12.3.8.6.1 Rest of Asia-Pacific Retinal Vein Occlusion Market by Type
12.3.8.6.2 Rest of Asia-Pacific Retinal Vein Occlusion Market by Condition
12.3.8.6.3 Rest of Asia-Pacific Retinal Vein Occlusion Market by Diagnosis
12.3.8.6.4 Rest of Asia-Pacific Retinal Vein Occlusion Market by Treatment
12.3.8.6.5 Rest of Asia-Pacific Retinal Vein Occlusion Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Retinal Vein Occlusion Market Overview
12.4.2 Middle East and Africa Retinal Vein Occlusion Market Forecasts and Analysis
12.4.3 Middle East and Africa Retinal Vein Occlusion Market Forecasts and Analysis - By Type
12.4.4 Middle East and Africa Retinal Vein Occlusion Market Forecasts and Analysis - By Condition
12.4.5 Middle East and Africa Retinal Vein Occlusion Market Forecasts and Analysis - By Diagnosis
12.4.6 Middle East and Africa Retinal Vein Occlusion Market Forecasts and Analysis - By Treatment
12.4.7 Middle East and Africa Retinal Vein Occlusion Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Retinal Vein Occlusion Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Retinal Vein Occlusion Market
12.4.8.1.1 South Africa Retinal Vein Occlusion Market by Type
12.4.8.1.2 South Africa Retinal Vein Occlusion Market by Condition
12.4.8.1.3 South Africa Retinal Vein Occlusion Market by Diagnosis
12.4.8.1.4 South Africa Retinal Vein Occlusion Market by Treatment
12.4.8.1.5 South Africa Retinal Vein Occlusion Market by End User
12.4.8.2 Saudi Arabia Retinal Vein Occlusion Market
12.4.8.2.1 Saudi Arabia Retinal Vein Occlusion Market by Type
12.4.8.2.2 Saudi Arabia Retinal Vein Occlusion Market by Condition
12.4.8.2.3 Saudi Arabia Retinal Vein Occlusion Market by Diagnosis
12.4.8.2.4 Saudi Arabia Retinal Vein Occlusion Market by Treatment
12.4.8.2.5 Saudi Arabia Retinal Vein Occlusion Market by End User
12.4.8.3 U.A.E Retinal Vein Occlusion Market
12.4.8.3.1 U.A.E Retinal Vein Occlusion Market by Type
12.4.8.3.2 U.A.E Retinal Vein Occlusion Market by Condition
12.4.8.3.3 U.A.E Retinal Vein Occlusion Market by Diagnosis
12.4.8.3.4 U.A.E Retinal Vein Occlusion Market by Treatment
12.4.8.3.5 U.A.E Retinal Vein Occlusion Market by End User
12.4.8.4 Rest of Middle East and Africa Retinal Vein Occlusion Market
12.4.8.4.1 Rest of Middle East and Africa Retinal Vein Occlusion Market by Type
12.4.8.4.2 Rest of Middle East and Africa Retinal Vein Occlusion Market by Condition
12.4.8.4.3 Rest of Middle East and Africa Retinal Vein Occlusion Market by Diagnosis
12.4.8.4.4 Rest of Middle East and Africa Retinal Vein Occlusion Market by Treatment
12.4.8.4.5 Rest of Middle East and Africa Retinal Vein Occlusion Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Retinal Vein Occlusion Market Overview
12.5.2 South and Central America Retinal Vein Occlusion Market Forecasts and Analysis
12.5.3 South and Central America Retinal Vein Occlusion Market Forecasts and Analysis - By Type
12.5.4 South and Central America Retinal Vein Occlusion Market Forecasts and Analysis - By Condition
12.5.5 South and Central America Retinal Vein Occlusion Market Forecasts and Analysis - By Diagnosis
12.5.6 South and Central America Retinal Vein Occlusion Market Forecasts and Analysis - By Treatment
12.5.7 South and Central America Retinal Vein Occlusion Market Forecasts and Analysis - By End User
12.5.8 South and Central America Retinal Vein Occlusion Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Retinal Vein Occlusion Market
12.5.8.1.1 Brazil Retinal Vein Occlusion Market by Type
12.5.8.1.2 Brazil Retinal Vein Occlusion Market by Condition
12.5.8.1.3 Brazil Retinal Vein Occlusion Market by Diagnosis
12.5.8.1.4 Brazil Retinal Vein Occlusion Market by Treatment
12.5.8.1.5 Brazil Retinal Vein Occlusion Market by End User
12.5.8.2 Argentina Retinal Vein Occlusion Market
12.5.8.2.1 Argentina Retinal Vein Occlusion Market by Type
12.5.8.2.2 Argentina Retinal Vein Occlusion Market by Condition
12.5.8.2.3 Argentina Retinal Vein Occlusion Market by Diagnosis
12.5.8.2.4 Argentina Retinal Vein Occlusion Market by Treatment
12.5.8.2.5 Argentina Retinal Vein Occlusion Market by End User
12.5.8.3 Rest of South and Central America Retinal Vein Occlusion Market
12.5.8.3.1 Rest of South and Central America Retinal Vein Occlusion Market by Type
12.5.8.3.2 Rest of South and Central America Retinal Vein Occlusion Market by Condition
12.5.8.3.3 Rest of South and Central America Retinal Vein Occlusion Market by Diagnosis
12.5.8.3.4 Rest of South and Central America Retinal Vein Occlusion Market by Treatment
12.5.8.3.5 Rest of South and Central America Retinal Vein Occlusion Market by End User

13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. RETINAL VEIN OCCLUSION MARKET, KEY COMPANY PROFILES
14.1. ALLERGAN PLC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. BAYER
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BRISTOL-MYERS SQUIBB
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ELLEX MEDICAL LASERS LTD
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. GLAXOSMITHKLINE PLC
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. IRIDEX CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. LUMENIS
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. NOVARTIS AG
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. NIDEK CO., LTD
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. REGENERON PHARMACEUTICALS
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Allergan PLC
2. Bayer
3. Bristol-Myers Squibb
4. Ellex Medical Lasers Ltd
5. GlaxoSmithKline PLC
6. IRIDEX Corporation
7. Lumenis
8. Novartis AG
9. NIDEK CO., LTD
10. Regeneron Pharmaceuticals
TIPRE00017831
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking